Location: Home
  • search
  • go
  • Relate News
  • 1/21/2019NMPA Holds National Drug Registration and Post-Marketing Regulation Co...
  • 1/18/2019Recent Executive Moves
  • 1/18/2019NHC and SATCM Issue Joint Notice for Inventory and Use of Essential Dr...
  • 1/18/2019China Approved Up To 59 New Drugs in 2018
  • 1/18/2019MabPlex's Manufactured mAb Receives IND Approval from the U.S. FDA
  • 1/18/2019CMBG’s AlloJoin the First Stem Cell Drug Application Approved in Chin...
  • 1/17/2019The State Council Issues Trial Plan for Nationally-Organized Centraliz...
  • 1/17/2019Boehringer Ingelheim Expands Biopharma Commercial Manufacturing in Chi...
  • 1/17/2019China's Patent Flood Stifles Foreign Filer Freedom
  • 1/17/2019China to Focus Corruption Fighting on Healthcare and Education Sectors
  • 1/16/2019AstraZeneca to Promote Luye Pharma's Cholesterol TCM in Mainland China
  • 1/16/2019Shanghai Introduces Point System for Physician Irregularities
  • 1/16/2019Bio-Thera Partners with Cipla to Market Key Cancer Biosimilar
  • 1/16/2019Ironwood Pharma Announces IBS Drug Linzess Approval in China
  • 1/16/2019Novo Nordisk Pharmatech A/S signs Asia Pacific distribution agreement ...
  • 1/16/2019Chinese mAb Market to Grow 13.7% CAGR between 2017 and 2022
  • 1/16/2019China's Biopharmas Buffeted by Clashing Market Dynamics
  • 1/15/2019SMEI Predicts Four China Healthcare Sector Trends in 2019
  • 1/15/2019Bayer Files IND of Loxo’s Novel Anticancer Vitrakvi in China
  • 1/15/2019China Pledges to Advance Poverty Alleviation in Healthcare
  • 1/15/2019Celltrion Set to Enter Chinese Pharmaceutical Market
  • 1/15/2019A New Scandal Involving Expired Polio Vaccine under Investigation
  • 1/15/2019Adagene Announces Collaboration for Discovery of Novel CAR-T with NIH ...
  • 1/15/2019BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubru...
  • 1/14/201994 Listed Chinese MedPharm Companies Release 2018 Performance Guidance
  • 1/14/2019Bayer Launches Hemophilia A Drug Kovaltry in China
  • 1/14/2019Ascletis and Alphamab Reach Agreement over Anti-PD-L1 for HBV
  • 1/13/2019NHC: 17 Anticancers with Negotiated BMI Inclusion in Most Hospitals No...
  • 1/13/2019NMPA Holds 2018 National Drug Regulation Conference
  • 1/13/2019China Approves New Indication of XiAN Janssen’s Remicade
  • Page:296/775 Total number of articles:23243: [First][<<] [294] [295] [296] [297] [298] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group